Outsourcing

The Lead

Merck Serono and Quintiles Announce Clinical Development Partnership

May 15, 2013 8:06 am | News | Comments

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services provider.

Merck Serono and Quintiles Announce Clinical Development Partnership

May 15, 2013 8:06 am | News | Comments

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, a provider of...

Merck Serono and Quintiles Announce Clinical Development Partnership

May 15, 2013 8:06 am | News | Comments

Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, a provider of...

Encapsulating Service

April 10, 2013 3:58 pm | by Jonnatha Mayberry, Associate Editor | Articles | Comments

Capsules are an important solid...

PAREXEL Report Defines Strategic Partnerships Between CROs and Biopharmaceutical Industry

April 22, 2013 9:53 am | News | Comments

PAREXEL International today released a new research report called Strategic Partnerships 2013. The report is the first to explore the current outsourcing landscape and the value Strategic Partnerships provide to biopharmaceutical companies of all sizes.

Covance Expands Singapore Central Laboratory by 50% to Meet Clients' Increased Asia Pacific Focus

April 16, 2013 8:05 am | News | Comments

Covance Inc. a provider of drug development services, today announced completion of the expansion of its central laboratory facility in Singapore to enhance the company's current service offerings and position it to meet current and future growth of drug development in the Asia Pacific region.

Outsourcing of Fill-Finish Operations Continues

April 15, 2013 9:38 am | by Eric Langer, President and Managing Partner, BioPlan Associates, Inc. | Articles | Comments

Fill-finish operations continue to be one of the most heavily outsourced activities in the biopharmaceutical manufacturing market today. This traditional field for outsourcing is something of a paradox. On one hand, this is a relatively low value-added operation; on the other hand, it deals with the finished product in its most valuable state, where the risks of a contamination event or other failure are at their highest.

Change is Good - Olympus Biotech's Diverse Past Has Prepared it for the Future

April 12, 2013 10:52 am | by Mike Auerbach, Editor in Chief | Articles | Comments

Olympus Biotech, a biopharmaceutical contract manufacturing organization (CMO) based in Lebanon, NH has seen plenty of change over its history and has emerged as a company with the expertise, experience, technologies and facilities to handle the inevitable changes the industry has in store.

Metrics Appoints Senior Director of Operations

January 31, 2013 7:05 am | News | Comments

Metrics Inc. has appointed Joe Cascone as senior director of operations. In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related operations such as engineering, environmental health and safety, and security.

Patheon Invests in Milton Park, UK Facility to Expand Early Development Capabilities in Europe

January 31, 2013 7:03 am | News | Comments

Patheon Inc., a provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans for additional investment in its Milton Park facility.

Kemwell Announces Successful Pre-NDA US FDA Inspection

January 31, 2013 3:05 am | News | Comments

Kemwell Biopharma Pvt. Ltd., a global pharmaceutical contract development and manufacturing company, announced today that its Oral Solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection.

Tapemark Expands Capabilities for Transdermal Patches

January 31, 2013 2:49 am | News | Comments

Tapemark has announced the addition of several new capabilities for transdermal patches, including the formulation, blending, and coating steps in the patch manufacturing process.

Parexel Posts Higher Profit, Lifts Outlook

January 30, 2013 3:32 am | News | Comments

Pharmaceutical research contractor Parexel International Corp. said on Tuesday that its fiscal second-quarter earnings jumped 65 percent as the company's backlog of contracts grew.

Metrics Names New VP of Pharmaceutical Development

January 29, 2013 3:19 am | News | Comments

Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.

AAIPharma Appoints Senior Director of Parenteral Operations

January 24, 2013 4:44 am | News | Comments

AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company's senior director of parenteral operations for its manufacturing facility in Charleston, S.C.

Irvine Pharmaceutical Services Brings Avrio Parenteral Manufacturing Facility Under Irvine Brand

January 23, 2013 4:58 am | News | Comments

Irvine Pharmaceutical Services announced today that it is incorporating its Avrio parenteral manufacturing facility into the Irvine brand.

AAIPharma Expands Laboratory Service Offerings and Capabilities in its Technology Center

January 22, 2013 3:16 am | News | Comments

AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today the expansion of laboratory service offerings, capabilities and instrumentation in its state-of-the-art laboratory Technology Center in Wilmington, N.C.

Norwich Pharmaceuticals Strengthens Development Expertise

January 17, 2013 4:38 am | News | Comments

Norwich Pharmaceuticals has announced that Kristin Arnold, Ph.D. has joined the company as vice president, product development and technical services (PDTS).

Almac Doubles Drug Product Development Capacity with a New Non-GMP Facility

January 14, 2013 2:57 am | News | Comments

Almac has announced the expansion of its drug product Pharmaceutical Development services with the creation of a new non-GMP formulation development facility and two new analytical laboratories at its UK headquarters in Craigavon.

AMRI Promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing

January 9, 2013 3:16 am | News | Comments

AMRI has announced that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately.

Almac and TTP Labtech Form Alliance in Fluorescence Lifetime Technology

January 7, 2013 2:58 am | News | Comments

Almac and TTP Labtech announced today the formation of an alliance in the field of fluorescence lifetime (FLT) technology to provide class leading screening performance.

AAIPharma Expands Capacity of Parenteral Manufacturing Facility

December 20, 2012 3:08 am | News | Comments

AAIPharma Services, a provider of pharmaceutical product development services, announced today that it is expanding the capacity and capabilities of its parenteral manufacturing facility in Charleston, S.C.

WuXi PharmaTech and PRA Form Joint Venture to Offer Clinical Research Services for Chinese Market

December 19, 2012 2:58 am | News | Comments

WuXi PharmaTech, a leading contract research organization with operations in China and the United States, and PRA, a leading global clinical contract research organization, today announced that they have signed a joint venture agreement to offer a broad platform of Phase I-IV clinical trial services in China, Hong Kong and Macau.

Elan Continues Separation of Drug Discovery Unit

December 17, 2012 3:21 am | News | Comments

NEW YORK (AP) — Irish drugmaker Elan Corp. PLC said Friday that it expects its former drug discovery business to become a separate publicly traded company on Dec. 21.

Geoff Glass Appointed President of Patheon's Proprietary Products Business Unit

December 17, 2012 3:05 am | News | Comments

Patheon Inc., a provider of contract development and manufacturing services to the global pharmaceutical industry, today announced, in connection with the close of the Banner acquisition, that Geoff Glass has been appointed president of the new proprietary products business unit.

Catalent and UMN Pharma Announce Collaboration for Biosimilar Development and Production in Japan

December 13, 2012 3:01 am | News | Comments

Catalent Pharma Solutions and UMN Pharma Inc. today announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent’s proprietary GPEx ® technology.

AAIPharma Promotes Dean Shirazi to EVP Of Analytical Laboratories

December 12, 2012 3:09 am | News | Comments

AAIPharma Services Corp., a provider of pharmaceutical product development services, announced today that it has promoted Dean Shirazi, Ph.D. to executive vice president of analytical laboratories.